Literature DB >> 8892916

Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins.

L D Cranmer1, C L Clark, C S Morello, H E Farrell, W D Rawlinson, D H Spector.   

Abstract

We have identified three open reading frames (ORFs) in murine cytomegalovirus (MCMV), designated M82, M83, and M84, which likely encode homologs of the human cytomegalovirus (HCMV) UL82 and UL83 matrix phosphoproteins. These ORFs, in the HindIII C fragment of MCMV, are colinear with the UL82, UL83, and UL84 ORFs of HCMV. M82 encodes a 598-amino-acid (aa) protein with homology to UL82, M83 encodes an 809-aa protein with homology to UL82 and UL83, and M84 encodes a 587-aa protein with homology to UL83 and UL84. Analysis of transcription by Northern (RNA) blotting indicated that the M82 and M83 ORFs are transcribed as 2.2- and 5-kb mRNAs, respectively, at 24 to 48 h postinfection (p.i.), while M84 is transcribed as a 6.9-kb mRNA only at 8 h p.i. All transcripts appear to terminate at the same position 3' of the M82 ORF. Of the products of the three ORFs, only M83 is strongly recognized by hyperimmune mouse serum. The M83 protein is a virion-associated phosphoprotein with an apparent molecular mass of 125 kDa. In MCMV-infected cells, it is detectable by Western blotting (immunoblotting) only at 48 h p.i. in the absence of phosphonoacetic acid, consistent with late gene expression. The M83 ORF is also expressed at high levels in cells infected by a recombinant vaccinia virus and yields a protein which is serologically cross-reactive and comigrates with the authentic MCMV protein in sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892916      PMCID: PMC190865     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  Translational inhibition by cytomegalovirus transcript leaders.

Authors:  B J Biegalke; A P Geballe
Journal:  Virology       Date:  1990-08       Impact factor: 3.616

Review 2.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Rapid and sensitive sequence comparison with FASTP and FASTA.

Authors:  W R Pearson
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

4.  Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs.

Authors:  M J Reddehase; F Weiland; K Münch; S Jonjic; A Lüske; U H Koszinowski
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

5.  Progressive alignment and phylogenetic tree construction of protein sequences.

Authors:  D F Feng; R F Doolittle
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

6.  The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties.

Authors:  G Jahn; B C Scholl; B Traupe; B Fleckenstein
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

7.  Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus.

Authors:  G Jahn; T Kouzarides; M Mach; B C Scholl; B Plachter; B Traupe; E Preddie; S C Satchwell; B Fleckenstein; B G Barrell
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

8.  Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection.

Authors:  M J Reddehase; U H Koszinowski
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

9.  In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection.

Authors:  M J Reddehase; W Mutter; U H Koszinowski
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

10.  Physical mapping of human cytomegalovirus genes: identification of DNA sequences coding for a virion phosphoprotein of 71 kDa and a viral 65-kDa polypeptide.

Authors:  B Nowak; A Gmeiner; P Sarnow; A J Levine; B Fleckenstein
Journal:  Virology       Date:  1984-04-15       Impact factor: 3.616

View more
  28 in total

1.  Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).

Authors:  R Holtappels; J Podlech; N K Grzimek; D Thomas; M F Pahl-Seibert; M J Reddehase
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs.

Authors:  R Holtappels; M F Pahl-Seibert; D Thomas; M J Reddehase
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Molecular characterization of the guinea pig cytomegalovirus UL83 (pp65) protein homolog.

Authors:  M R Schleiss; A McGregor; N J Jensen; G Erdem; L Aktan
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

4.  New genes from old: redeployment of dUTPase by herpesviruses.

Authors:  Andrew J Davison; Nigel D Stow
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 5.  Differences between mouse and human cytomegalovirus interactions with their respective hosts at immediate early times of the replication cycle.

Authors:  Gerd G Maul; Dmitri Negorev
Journal:  Med Microbiol Immunol       Date:  2008-02-09       Impact factor: 3.402

6.  Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challenge.

Authors:  Christopher S Morello; Ming Ye; Stephanie Hung; Laura A Kelley; Deborah H Spector
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

7.  Murine cytomegalovirus downregulates interleukin-17 in mice with retrovirus-induced immunosuppression that are susceptible to experimental cytomegalovirus retinitis.

Authors:  Emily L Blalock; Hsin Chien; Richard D Dix
Journal:  Cytokine       Date:  2013-02-14       Impact factor: 3.861

8.  Inactivation of enveloped virus by laser-driven protein aggregation.

Authors:  Shaw-Wei D Tsen; Travis Chapa; Wandy Beatty; Kong-Thon Tsen; Dong Yu; Samuel Achilefu
Journal:  J Biomed Opt       Date:  2012-12       Impact factor: 3.170

9.  Molecular, biological, and in vivo characterization of the guinea pig cytomegalovirus (CMV) homologs of the human CMV matrix proteins pp71 (UL82) and pp65 (UL83).

Authors:  Alistair McGregor; Fenyong Liu; Mark R Schleiss
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Properties of virion transactivator proteins encoded by primate cytomegaloviruses.

Authors:  Iain P Nicholson; Jane S Sutherland; Tanya N Chaudry; Earl L Blewett; Peter A Barry; Mary Jane Nicholl; Chris M Preston
Journal:  Virol J       Date:  2009-05-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.